Infosys clinches $1.6 billion NHS deal, closing revenue gap with Cognizant. Investors eye growth, AI strategy, and margins ...
Infosys (INFY) faces short-term challenges but is investing in AI for future growth. Learn why now may be the time to hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback